European Leukemia Trial Registry
Trial: MDS-005

More Details
Title A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q (MDS-005)
Scientific Title A Phase 3, Multicenter, Placebo-Controlled Study to Compare the Efficacy and Safety of Lenalidomide vs. Placebo in Subjects With Transfusion Dependent Anemia Due to Low or Intermediate Risk MDS and Unresponsive to ESA Therapies
Short Title MDS-005
Trialgroup NN
Type of Trial multicentric, randomized
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.08.2008
Leader Hofmann , Prof. Dr. med., Wolf-K.
Contactperson

principal investigator
Hofmann , Prof. Dr. med., Wolf-K.
Tel: +49 (0)30 8445-3421
Fax: +49 (0)30 8445-3425
Email: W.K.Hofmann@charite.de

Shortprotocol Shortprotocol
Remark further information: http://www.klinisches-studienzentrum.de/cio/en/trial/879 http://clinicaltrials.gov/ct2/show/study/NCT01029262#locn
created 23.11.2010 Johannes Kraus
changed 16.04.2013 Sina Hehn
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org